M3B Fundamental Analysis - PYRAMID AG

Fundamental Rating

Overall M3B gets a fundamental rating of 2 out of 10. We evaluated M3B against 30 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and financial health of M3B have multiple concerns. While showing a medium growth rate, M3B is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year M3B has reported negative net income.

The reported net income has been mixed in the past 5 years: M3B reported negative net income in multiple years.

M3B had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of M3B (-0.29%) is worse than 63.33% of its industry peers.

M3B's Return On Equity of -0.48% is in line compared to the rest of the industry. M3B outperforms 50.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-0.29%
ROE	-0.48%
ROIC	N/A

ROA(3y)2.26%

ROA(5y)-2.19%

ROE(3y)3.1%

ROE(5y)-2.17%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

M3B has a worse Gross Margin (-434.35%) than 93.33% of its industry peers.

M3B's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for M3B so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	-434.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-13.41%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

M3B has more shares outstanding than it did 1 year ago.

The number of shares outstanding for M3B has been increased compared to 5 years ago.

The debt/assets ratio for M3B is higher compared to a year ago.

2.2 Solvency

M3B has an Altman-Z score of 0.31. This is a bad value and indicates that M3B is not financially healthy and even has some risk of bankruptcy.

M3B's Altman-Z score of 0.31 is on the low side compared to the rest of the industry. M3B is outperformed by 70.00% of its industry peers.

M3B has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.

M3B's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. M3B outperforms 66.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Altman-Z	0.31

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 2.94 indicates that M3B has no problem at all paying its short term obligations.

The Current ratio of M3B (2.94) is better than 83.33% of its industry peers.

A Quick Ratio of 1.08 indicates that M3B should not have too much problems paying its short term obligations.

M3B's Quick ratio of 1.08 is in line compared to the rest of the industry. M3B outperforms 56.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.94
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for M3B have decreased strongly by -150.00% in the last year.

M3B shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -115.30%.

The Revenue has been growing by 143.51% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-150%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-450%

Revenue 1Y (TTM)-115.3%

Revenue growth 3Y441.32%

Revenue growth 5Y143.51%

Sales Q2Q%-19.28%

3.2 Future

The Earnings Per Share is expected to grow by 37.15% on average over the next years. This is a very strong growth

M3B is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.84% yearly.

EPS Next Y-140%

EPS Next 2Y100%

EPS Next 3Y68.69%

EPS Next 5Y37.15%

Revenue Next Year10.57%

Revenue Next 2Y17.03%

Revenue Next 3Y17.22%

Revenue Next 5Y14.84%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for M3B. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for M3B. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

M3B's earnings are expected to grow with 68.69% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y100%

EPS Next 3Y68.69%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

M3B does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

PYRAMID AG

FRA:M3B (1/5/2026, 7:00:00 PM)

0.854

-0.01 (-0.7%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryTechnology Hardware, Storage & Peripherals

Earnings (Last)11-14 2025-11-14

Earnings (Next)02-18 2026-02-18

Inst Owners2.11%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap19.70M

Revenue(TTM)-5.99M

Net Income(TTM)-211.00K

Analysts80

Price Target1.68 (96.72%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.45
P/tB	1.51
EV/EBITDA	N/A

EPS(TTM)-0.02

EYN/A

EPS(NY)-0.06

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS-0.26

BVpS1.89

TBVpS0.56

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.29%
ROE	-0.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	-434.35%
FCFM	N/A

ROA(3y)2.26%

ROA(5y)-2.19%

ROE(3y)3.1%

ROE(5y)-2.17%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-13.41%

F-ScoreN/A

Asset Turnover-0.08

Health

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.94
Quick Ratio	1.08
Altman-Z	0.31

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-150%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-450%

EPS Next Y-140%

EPS Next 2Y100%

EPS Next 3Y68.69%

EPS Next 5Y37.15%

Revenue 1Y (TTM)-115.3%

Revenue growth 3Y441.32%

Revenue growth 5Y143.51%

Sales Q2Q%-19.28%

Revenue Next Year10.57%

Revenue Next 2Y17.03%

Revenue Next 3Y17.22%

Revenue Next 5Y14.84%

EBIT growth 1Y-350.05%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year294.18%

EBIT Next 3Y98.02%

EBIT Next 5Y54.74%

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

ChartMill assigns a fundamental rating of 2 / 10 to M3B.DE.

What is the valuation status for M3B stock?

ChartMill assigns a valuation rating of 1 / 10 to PYRAMID AG (M3B.DE). This can be considered as Overvalued.

What is the profitability of M3B stock?

PYRAMID AG (M3B.DE) has a profitability rating of 1 / 10.

PYRAMID AG (M3B.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

What is the valuation status for M3B stock?

What is the profitability of M3B stock?